Thank you for being here Jordan Starkman, President of Rimrock Gold Corp., for this interview. PennyStocks.News has prepared a list of questions for you.
Date of Interview: 06/14/2021.
PSN: For those who are not (or little) familiar with your company. What is the best way to describe Rimrock Gold Corp., and its activities?
Jordan Starkman: Thank-you very much for the interview. Rimrock Gold Corp strives to be a leader in the sale of CBD products throughout the US, with a long-term initiative to provide consumers with the greatest selection of wellness-centered products. Through our wholly owned subsidiary Acqua Cannabis Corp., we offer a number of truly fantastic products. Most notably, our Acqua CBD Coffee, which is infused with resveratrol and, of course, CBD (acquacbdcoffee.com). Next, we have our Acqua Cannabis site (acquacannabis.com), where we sell a variety of cannabinoid tinctures, including combinations with Delta 8, plus Delta 8 gummies, which is we wholeheartedly believe is the best on the market. All products are lab tested, 100% natural, and non-GMO. Our latest product launch is a seamless addition to our wellness-centered products; AstoundNMN NMN supplements. This product is an innovative supplement, which has numerous health benefits including anti-aging.
PSN: As for the name itself, will Rimrock Gold Corp. be the definitive name for your company, or will there be a name change? And if so, when exactly?
Jordan Starkman: The Company is currently evaluating the idea of a name change that would be more reflective of the current business operations. We will certainly notify shareholders of our intent when the time comes.
PSN: What is your current view and expectations for the Cannabis and CBD market and what was your reasoning to step into these markets?
Jordan Starkman: We believe the cannabis and CBD markets are still in their infancy stage. The global cannabidiol market size is expected to reach USD 13.4 billion by 2028. The market is expected to expand at a CAGR of 21.2% from 2021 to 2028.Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, and attitude toward CBD products are some of the key factors driving the demand for these products. Furthermore, increasing demand for cannabidiol from various end-user industries such as food and beverage, personal care and cosmetics, and pharmaceuticals is expected to trigger market growth. Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period.
In 2020, the hemp segment accounted for the largest revenue share valued at USD 1.7 billion, owing to the rising awareness regarding the health benefits of products infused with cannabidiol derived from marijuana. On the other hand, hemp-derived CBD is expected to witness the fastest CAGR over the forecast period, owing to the increasing legalization of hemp in various countries.
PSN: Your latest news is about your new product containing NMN, which will be added to your line up of CBD products. Can you tell us and the readers what NMN is about and why it was added to your lineup?
Jordan Starkman: To fully understand NMN, we must first understand NAD+. NAD+, or nicotinamide adenine dinucleotide, is a molecule that naturally occurs in all life forms. NAD+ is a coenzyme that converts nutrient energy so that it can be used by cells. The levels of NAD+ in someone’s cells determines the speed of their aging process. The molecule acts as a coenzyme in many critical biological processes, including metabolism, aging, cell death, DNA repair, and gene expression.
NMN, or nicotinamide mononucleotide, like NAD+, is a molecule naturally occurring in all life forms. It is a vitamin B3 (niacin) derivative, which can also be found in various vegetables, fruits, and meat. In its naturally produced state, NMN is a precursor to NAD+, meaning it becomes NAD+ through a series of chemical transformations. When ingested, NAD+ and NMN do not have the same capacity – NAD+ cannot travel through the blood-brain route, ultimately keeping the molecule and its from penetrating cells. Conversely, NMN is able to travel the blood-brain route and enter cells, proving it a successful way to increase NAD+ levels. Thus, helping restore cellular energy, support healthy brain function, and promote anti-aging throughout the entire body. NAD+ is essential in human life, health, and longevity. It plays a vital role in cellular metabolism, turning nutrients into cellular energy, and activating sirtuins, a set of proteins that repair DNA. NAD+ levels decrease as we age due to environmental factors, stress, and various other factors. In fact, it is believed that the levels of NAD+ in someone’s cells determines the speed of their aging process. Decreased NAD+ levels are also responsible for many age-related conditions like cardiovascular disease, neurodegenerative diseases, and cancer.
PSN: We also read that some of your products contain anti-aging properties. How can your consumers and perhaps your shareholders be sure and confident of the results that your products are said to cause?
Jordan Starkman: Research on NMN, or Nicotinamide Mononucleotide, has taken great strides in recent years, and while there is still much to learn, it is a promising, innovative supplement that we believe in and are thrilled to be offering. I think a great place for shareholders to fully understand NMN is our AstoundNMN site (AstoundNMN.com), as well as NMN.com.
PSN: Your company promotes and sells many cannabis infused products. Why do you believe the consumer should choose these products instead of alternatives without infused cannabis?
Jordan Starkman: As they say every edible is not created equal. There are significant differences between infused CBD and sprayed CBD. As the name suggests, sprayed edibles are simply gummies, candies, or even cookies which have been sprayed over with CBD oils or THC distillates. These candies and gummies taste great and are cheap too because the manufacturers of these products simply purchase these gummies in bulk, spray and coat them with a powered mixture of CBD and sugar and call it a day. The problem arises here for coated or sprayed edibles do not compare in quality, efficiency, or shelf life to actual products which have actually been infused with cannabinoid compounds. In comparison, infusing cannabinoids like THC and CBD into edibles is a much more difficult procedure. The decarboxylation process is extremely important as it brings out the psychoactive properties in THC and the medicinal ones in CBD. Infused edibles test more accurately in terms of cannabinoid content, than an edible which has been sprayed or coated. In addition, cannabinoids in an infused edible have a much longer shelf life which in turn results in a higher potency and effectiveness. Since a manufacturer is legally required to disclose how much CBD or THC has been infused in each gummy, the infusion process can be more effectively measured and dosed.
PSN: As you know, CBD is not legal in all 50 states, how do you believe this will change in the next upcoming years and how will that impact RMRK?
Jordan Starkman: We believe that cannabis will be legalized at the federal level in the US within the next year or two. This will open the door for increased competition and consolidation within the market. Prior to legalization taking place the company’s goal is to differentiate ourselves from the competition by entering different and unique spaces such as NMN with CBD. Additionally, we place importance on our marketing mix, as we believe that superior and thoughtful marketing techniques are of upmost importance in the space.
PSN: As was stated within your news release: “we are actively looking to expand our consumer reach across the U.S.” How do you and your company tackle this goal?
Jordan Starkman: The main goal for the company at this time is to increase its marketing campaign. We have been making significant strides in getting our products into the marketplace besides online sales. We are currently looking at additional distribution strategies for various products, which we will update shareholders on as progression is made.
PSN: We have seen that the company owns the subsidiary, AstoundNMN and its website. Could you tell us more about its sales, revenue, future forecasts and about its products?
Jordan Starkman: Our newly launched brand, Astound NMN has seen somewhat limited sales as it stands. However, this is primarily due to the nature of the product; NMN is a newly discovered product, and while research is promising, it has not had much time on the market to become recognizable and understood by consumers. That being said, as more information is released and NMN becomes known to more, our growth and sales expectations are aligned. We are thrilled to be early adopters of this astounding product.
PSN: How financially healthy is RMRK and its subsidiaries, regarding their: revenue and debts?
Jordan Starkman: The Company is currently considered to be in the development stage, and we have only recently starting selling products online. We expect to clean-up the company’s financial statements during next quarter. As it stands, we assume a portion of our liabilities will be removed from the financial statements. This includes debt that has been forgiven or settled, as well as shares to-be-issued, which represents a liability for the Company.
PSN: Does the company have any plans to reverse split, increase of Authorized shares and Outstanding shares or dilution
Jordan Starkman: At this time, the Company does not have plans for a reverse-split. Additionally, we have no convertible debt on the books. There are shares to-be-issued on the financial statements, however it is not a significant amount. If the company raises capital, it will be through the issuance of shares, however the shares are restricted for a year and will not affect the float.
PSN: Are there plans set for a buyback of your company’s shares?
Jordan Starkman: There are no plans for a share buyback. Any free cash the Company has will be directed towards marketing expenses and other avenues to grow the business.
PSN: Are there any plans to uplift your company to Nasdaq. And if so, what will be the timeframe and your plan for this?
Jordan Starkman: A Nasdaq listing is in our long terms plans contingent upon our net assets and revenue.
PSN: We know that there is no dilution. However, are you planning to add more ventures and if yes, do you have the capital to do so without dilution?
Jordan Starkman: We believe that any share issuances for acquisitions or capital raises will not affect the free trading shares or float in the market. In addition, the issuance of shares will only benefit the Company and shareholders in the long run.
The Company is currently seeking to raise capital for the Company’s operations. Likely, that could involve the issuance of restricted shares from treasury.
PSN: Will there be a physical location for the company itself?
Jordan Starkman: The Company is currently toying with the idea of an Acqua Cannabis store in New York. The concept is still in very early stages, so for now we remain strictly online.
PSN: Is there anything that has not been discussed in this interview about Rimrock Gold Corp. that you would like to share with us?
Jordan Starkman: The Company continues to move forward and we are always seeking new opportunities to further grow the Company. We are open to acquisitions and have been evaluating a few potential transactions. We believe that any acquisition would propel our company’s growth plans and significantly increase shareholder value.
Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision. .